Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Efavirenz or Nevirapine in Three‐drug Combination Therapy With Two Nucleoside or Nucleotide‐reverse Transcriptase Inhibitors for Initial Treatment of HIV Infection in Antiretroviral‐naïve Individuals." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439305/2/images/tooltip-triangle.png. Accessed 05 May 2024.
Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/2/images/tooltip-triangle.png. Accessed May 5, 2024.
Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/2/images/tooltip-triangle.png
Efavirenz or Nevirapine in Three‐drug Combination Therapy With Two Nucleoside or Nucleotide‐reverse Transcriptase Inhibitors for Initial Treatment of HIV Infection in Antiretroviral‐naïve Individuals [Internet]. In: Cochrane Abstracts. [cited 2024 May 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/2/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Efavirenz or nevirapine in three‐drug combination therapy with two nucleoside or nucleotide‐reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral‐naïve individuals
ID - 439305
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439305/2/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -